PT  - JOURNAL ARTICLE
AU  - , 
TI  - HPV Vaccine Recommendations
AID  - 10.1542/peds.2011-3865
DP  - 2012 Mar 01
TA  - Pediatrics
PG  - 602--605
VI  - 129
IP  - 3
4099  - http://pediatrics.aappublications.org/content/129/3/602.short
4100  - http://pediatrics.aappublications.org/content/129/3/602.full
SO  - Pediatrics2012 Mar 01; 129
AB  - On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.Abbreviations:AAP — American Academy of PediatricsHPV — human papillomavirusHPV2 — bivalent human papillomavirus vaccineHPV4 — quadrivalent human papillomavirus vaccine